MedTrace Logo

MRI Guided HIFU for Palliation of Painful Skeletal Metastases in Children

NCT02616016 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-05-03

No results posted yet for this study

Summary

The Philips Sonalleve MR-HIFU system is expected to be effective in reducing pain intensity and/or reducing analgesic use in patients with painful uncomplicated bone metastases. No serious adverse effects are expected to result from this treatment.

Conditions

Interventions

DEVICE

MRI Guided High Intensity Focused Ultrasound

Target treatment of bone metastases using High Intensity Focused Ultrasound

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • James M Drake, FRCSC,FACS · The Hospital for Sick Children

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2024-05-02
Completion
2024-05-02

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616016 on ClinicalTrials.gov